Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-29
2007-05-29
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S474000, C549S222000
Reexamination Certificate
active
10510756
ABSTRACT:
An ascorbic acid derivative, which is a compound represented by the following general formula (1) or a salt thereof: [Chemical Formula 11] (1)(wherein X and Y each represents H or a protective group for OH, R1and R2each represents an alkyl group having from 1 to 19 carbon atoms, which may be linear or branched, and the total number of carbon atoms in R1R2is an integer of 5 to 22).
REFERENCES:
patent: 3658848 (1972-04-01), Nomura et al.
patent: 4939128 (1990-07-01), Kato et al.
patent: 0 875 246 (1998-11-01), None
patent: 0 875 514 (1998-11-01), None
patent: 1 074 242 (2001-02-01), None
patent: 1 264 600 (2002-12-01), None
patent: 52-18191 (1977-05-01), None
patent: 58 222078 (1983-12-01), None
patent: 61 050908 (1986-03-01), None
patent: 61050908 (1986-03-01), None
International Search Report dated on Jul. 7, 2003.
Chinese Office Action dated Jan. 20, 2006.
Ishii Hiroshi
Nishimura Norihito
Saito Makoto
Rahmani Niloofar
Seaman Margaret D.
Showa Denko K.K.
Sughrue & Mion, PLLC
LandOfFree
Stabilized ascorbic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized ascorbic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized ascorbic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3763952